Sign Out
Pregnancy: There are no specific study data on the use of Optive Fusion/Optive Fusion UD during pregnancy and lactation in humans; however, animal studies with CMC have not demonstrated any harmful effects in pregnancy. Animal studies using glycerin have shown no evidence of teratogenicity.
Lactation: Optive Fusion/Optive Fusion UD has also not been studied in breast-feeding women; however, Optive Fusion/Optive Fusion UD is not expected to have significant systemic absorption; therefore, it would not be excreted in human breast milk.
Continue with Google